Gene patenting

American College of Medical Genetics (ACMG), "Position Statement on Gene Patents and Accessibility of Gene Testing," Genet Aw. Med., 1, 237 (1999). 

College of American Pathologists (CAP), Gene Patents Detrimental to Care, Training, Research (July 5,2000), www.cap.org/html/advocacy/issues/genetalk.html (last visited June 21, 2002). 

In contrast, the Tay-Sachs disease test patented by the Department of Health and Human Services costs about 100 per test, and the screening test for two breast cancer genes patented by a biotechnology firm costs 2,400 per test (Krimsky, 1999). 

Ontario Ministry of Health (2002). Genetics, Testing and Gene Patenting Charting New Territory in Healthcare. Government of Ontario, Toronto, Canada. 

Williams-Jones B (2002). History of a gene patent Tracing the development and application of commercial BRCA testing. Health Law J. 10 123-146. 

Caulfield T (2005). Policy conflict Gene patents and health care in Canada. Community Genet. 8 223-227. 

D. Resnik, Discoveries, inventions, and gene patents in Wfto Owns Life (Eds. D. Magnus, A. Caplan, G. McGee), Prometheus Press, New York, 2002, pp. 171-181. 

G. Woolett, O. Hammond, An industry perspective on the gene patenting debate in Perspectives on Gene Patenting (Ed. A. Chapman), American Association for the Advancement of Science, Washington, 1999, pp. 43-50. 

---